EFFICACY AND TOLERABILITY OF PRIVIGEN® (IGPRO10) IN PRIMARY AND SECONDARY IMMUNODEFICIENCIES - A MULTICENTER OBSERVATIONAL STUDY

被引：0
|
作者：
Otremba, B.
Slawik, H. R.
Tschechne, B. [1 ]
Lotichius, P.
Pfruender, D. [2 ]
机构：
[1] Tagesklin Krankenhaus, Neustadt A Rbge, Germany
[2] CSL Behring, Hattersheim, Germany
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2012年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：158 / 159
页数：2
相关论文
共 50 条
  • [21] Efficacy and tolerability of lacosamide for secondary epileptic seizures in patients with brain tumor: A multicenter, observational retrospective study
    Manuel Sepulveda-Sanchez, Juan
    Conde-Moreno, Antonio
    Baron, Manuel
    Pardo, Javier
    Reynes, Gaspar
    Belenguer, Antonio
    ONCOLOGY LETTERS, 2017, 13 (06) : 4093 - 4100
  • [22] Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections
    Lahue, Betsy J.
    Mallick, Rajiv
    Zhang, Xiang
    Heidt, Julien
    Song, Yufei
    Koenig, Andrew S.
    Espinoza, Gabriela
    IMMUNOTHERAPY, 2022, 14 (15) : 1245 - 1261
  • [23] Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports
    Shebl, Amgad
    Gabriel, Susie
    Van Dinther, Kristy
    Hubsch, Alphonse
    Lawo, John-Philip
    Hoefferer, Liane
    Welsh, Susan
    TRANSFUSION, 2020, 60 (06) : 1278 - 1286
  • [24] Tolerability and efficacy of the intravenous immunoglobulins octagam® 5% and octagam® 10% in secondary immunodeficiencies - Interim analysis of a non-interventional study
    Tschechne, B.
    Jansen, M.
    Klein, I
    Lietz, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 297 - 297
  • [25] Efficacy and Safety of Intravenous Immunoglobulin (IVIG) IgPro10 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): the PRIMA and PATH studies
    Mielke, Orell
    van Schaik, Ivo N.
    Leger, Jean-Marc
    Bril, Vera
    van Geloven, Nan
    Hartung, Hans-Peter
    Lewis, Richard A.
    Sobue, Gen
    Lawo, John-Philip
    Durn, Billie
    De Bleecker, Jan
    Cornblath, David R.
    Sommer, Claudia
    Robberecht, Wim
    Saarela, Mika
    Kamienowski, Jerzy
    Stelmasiak, Zbigniew
    Tackenberg, Bjorn
    Merkies, Ingemar S. J.
    NEUROLOGY, 2018, 90
  • [26] A 10% liquid immunoglobulin preparation for intravenous use (Privigen®) in paediatric patients with primary immunodeficiencies and hypersensitivity to IVIG
    Lozano-Blasco, J.
    Martin-Mateos, M. A.
    Alsina, L.
    Dominguez, O.
    Giner, M. T.
    Piquer, M.
    Alvaro, M.
    Plaza, A. M.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2014, 42 (02) : 136 - 141
  • [27] Infections in Secondary Immunodeficiency Patients Treated with IgPro10: A Real-Word Analysis of Patients, Including Those with Hematological Malignancies
    Lahue, Betsy
    Mallick, Rajiv
    Zhang, Xiang
    Koenig, Andrew S.
    Espinoza, Gabriela
    BLOOD, 2021, 138
  • [28] Similar Efficacy and Pharmacokinetic Behavior of Intravenous Immunoglobulin (Privigen®) in Primary and Secondary Immunodeficiency
    Rojavin, Mikhail
    Lawo, John-Philip
    Jochems, Jeanine
    Puli, Shilpa
    Hofmann, Jutta
    Pfruender, Dietmar
    Tortorici, Michael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB216 - AB216
  • [29] Efficacy and safety of intravenous Immunoglobulin (IVIG) IgPro10 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): combined analysis of the PRIMA and PATH studies
    Merkies, I. S.
    Leger, J-M
    Bril, V.
    van Geloven, N.
    Hartung, H-P
    Lewis, R. A.
    Sobue, G.
    Lawo, J-P
    Durn, B. L.
    Cornblath, D. R.
    de Bleecker, J.
    Sommer, C.
    Robberecht, W.
    Saarela, M.
    Kamienowski, J.
    Stelmasiak, Z.
    Tackenberg, B.
    Mielke, O.
    van Schaik, I. N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 468 - 469
  • [30] Efficacy And Tolerability Of Perampanel In The Treatment Of Progressive Myoclonus Epilepsies. An Italian Multicenter Observational Study
    Canafoglia, L.
    Barbella, G.
    Ferlazzo, E.
    Striano, P.
    Magaudda, A.
    d'Orsi, G.
    Sueri, C.
    Giuliano, L.
    Sofia, V.
    Zibordi, F.
    Ragona, F.
    Freri, E.
    Costa, C.
    Cesarini, E. Nardi
    Fanella, M.
    Sebastiano, D. Rossi
    Riguzzi, P.
    Gambardella, A.
    Di Bonaventura, C.
    Michelucci, R.
    Granata, T.
    Bisulli, F.
    Licchetta, L.
    Beccaria, F.
    Visani, E.
    Franceschetti, S.
    EPILEPSIA, 2019, 60 : 151 - 152
12345